Andrea Drera
YOU?
Author Swipe
View article: Eight-month angiographic outcomes and in-stent restenosis in patients undergoing percutaneous coronary intervention on unprotected left main coronary artery
Eight-month angiographic outcomes and in-stent restenosis in patients undergoing percutaneous coronary intervention on unprotected left main coronary artery Open
In-stent restenosis (ISR) remains a significant complication of percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) disease, with potentially severe consequences. This study aimed to evaluate the incidence and pre…
View article: Exploring the Cardiorenal Benefits of SGLT2i: A Comprehensive Review
Exploring the Cardiorenal Benefits of SGLT2i: A Comprehensive Review Open
The history of sodium-glucose cotransporter 2 inhibitors (SGLT2i) is so long and started in 1835 when Petersen extracted a compound called phlorizin from apple tree bark. About fifty years later, von Mering discovered its glucosuric proper…
View article: Endothelial Dysfunction in Heart Failure: What Is Its Role?
Endothelial Dysfunction in Heart Failure: What Is Its Role? Open
The endothelium is a continuous layer of cells that coats the interior walls of arteries, capillaries, and veins. It has an essential regulatory role in hemostatic function, vascular tone, inflammation, and platelet activity. Endothelial d…
View article: Coeliac and cardiovascular disease: a possible relationship between two apparently separate conditions
Coeliac and cardiovascular disease: a possible relationship between two apparently separate conditions Open
Coeliac disease (CD) is an autoimmune condition with a high prevalence among general population and multisystemic involvement: a more complex scene than a merely gastrointestinal disease. Therefore, an early diagnosis and treatment with a …
View article: 170 Evaluation of endothelial function in dyslipidaemic patients treated with anti-PCSK9 monoclonal antibody
170 Evaluation of endothelial function in dyslipidaemic patients treated with anti-PCSK9 monoclonal antibody Open
Aims According to new Guidelines, the use of an anti-PCSK9 monoclonal antibody in combination is recommended in secondary prevention in patients with very high risk who do not reach the target with the maximum tolerated dose of statin and …